Govt panel recommends against allowing Serum Institute to conduct phase 2/3 trial of Covovax vaccine on children aged 2-17 years: Sources.

Govt panel recommends against allowing Serum Institute to conduct phase 2/3 trial of Covovax vaccine on children aged 2-17 years: Sources.